Trulieve Cannabis (OTCMKTS:TCNNF) Stock Price Up 1.6%

Trulieve Cannabis Corp. (OTCMKTS:TCNNF) shares rose 1.6% during mid-day trading on Friday . The company traded as high as $6.01 and last traded at $5.78. Approximately 1,068,520 shares traded hands during trading, an increase of 191% from the average daily volume of 367,201 shares. The stock had previously closed at $5.69.

Wall Street Analyst Weigh In

TCNNF has been the topic of a number of research reports. Wedbush lowered their target price on shares of Trulieve Cannabis from $8.00 to $6.00 and set an “outperform” rating on the stock in a research report on Friday, August 11th. Stifel Nicolaus raised their target price on shares of Trulieve Cannabis from C$8.00 to C$9.00 in a research report on Thursday, August 10th. Alliance Global Partners lowered their target price on shares of Trulieve Cannabis from C$24.00 to C$16.00 in a research report on Thursday, May 11th. Finally, Needham & Company LLC lowered their target price on shares of Trulieve Cannabis from $10.00 to $9.00 and set a “buy” rating on the stock in a research report on Thursday, August 10th.

Trulieve Cannabis Stock Performance

The firm has a 50 day moving average price of $4.15 and a 200-day moving average price of $4.88.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands.